Physician No program year No payments reported Source: CMS Open Payments, 2026 publication

Cathy Hurley

Internal Medicine Kerrville, TX

NPI 1265432835 CMS profile 192638

703 Hill Country Dr, Suite 301, Kerrville, TX 78028

Open in the dashboard

General payments

$0

None reported

Research payments

$0

Paid to them · None reported

Ownership & investment interest

$0

None reported

The CMS Open Payments record contains no reported payments to Cathy Hurley of Kerrville, TX.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

Prescribing to Medicare patients

Part D · data year 2024 · 20 drugs

Part D claims

27,782

Median for Internal Medicine: 777

Drug cost

$6,188,861

Median for Internal Medicine: $73,373

Branded share of claims

99%

Median for Internal Medicine: 19.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Arexvy Rsvpref3 Antigen/As01e/Pf Brand 11,344 $3,361,848
Shingrix Varicella-Zoster Ge/As01b/Pf Brand 9,430 $1,989,728
Abrysvo Rsv Vacc, Pref A And Pref B/Pf Brand 1,401 $424,993
Boostrix Tdap Diphth,pertuss(Acell),tet Vac Brand 4,055 $264,465
Twinrix Hepatitis A And B Vaccine/Pf Brand 426 $60,202
Adacel Tdap Diph,pertuss(Acell),tet Vac/Pf Brand 370 $24,295
Typhim Vi Typhoid Vi Polysacch Vaccine Brand 88 $13,155
Yf-Vax Yellow Fever Vaccine Live/Pf Brand 45 $9,344
Havrix Hepatitis A Virus Vaccine/Pf Brand 86 $8,466
Atovaquone-Proguanil Hcl Atovaquone/Proguanil Hcl Brand 110 $7,760

The 10 drugs with the highest cost, of 20 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.

Other Internal Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record